The contribution of residues 192 and 193 to the specificity of snake venom serine proteinases

被引:34
作者
Braud, S
Parry, MAA
Maroun, R
Bon, C
Wisner, A
机构
[1] Inst Pasteur, Unite Venins, F-75724 Paris 15, France
[2] Max Planck Inst Biochem, Dept Struct Res, D-82152 Martinsried, Germany
关键词
D O I
10.1074/jbc.275.3.1823
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Snake venom serine proteinases, which belong to the subfamily of trypsin-like serine proteinases, exhibit a high degree of sequence identity (60-66%). Their stringent macromolecular substrate specificity contrasts with that of the less specific enzyme trypsin, One of them, the plasminogen activator from Trimeresurus stejnegeri venom (TSV-PA), which shares 63% sequence identity with batroxobin, a fibrinogen clotting enzyme from Bothrops atrox venom, specifically activates plasminogen to plasmin like tissue-type plasminogen activator (t-PA), even though it exhibits only 23% sequence identity with t-PA This study shows that TSV-PA, t-PA, and batroxobin are quite different in their specificity toward small chromogenic substrates, TSV-PA being less selective than t-PA, and batroxobin not being efficient at all, The specificity of TSV-PA, with respect to t-PA and batroxobin, was investigated further by site directed mutagenesis in the 189-195 segment, which forms the basement of the S-1 pocket of TSV-PA and presents a His at position 192 and a unique Phe at position 193, This study demonstrates that Phe(193) plays a more significant role than His(192) in determining substrate specificity and inhibition resistance. Interestingly, the TSV-PA variant F193G possesses a 8-9-fold increased activity for plasminogen and becomes sensitive to bovine pancreatic trypsin inhibitor.
引用
收藏
页码:1823 / 1828
页数:6
相关论文
共 29 条
[1]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[2]  
Bode W, 1983, Adv Exp Med Biol, V156, P289
[3]  
COLLEN D, 1991, BLOOD, V78, P3114
[4]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[5]   MUTATIONS AFFECTING THE ACTIVITY OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR [J].
DAVIDOW, LS ;
DUMAIS, DR ;
SMYTH, AP ;
GREER, J ;
MOIR, DT .
PROTEIN ENGINEERING, 1991, 4 (08) :923-928
[6]   CONVERTING TRYPSIN TO CHYMOTRYPSIN - THE ROLE OF SURFACE LOOPS [J].
HEDSTROM, L ;
SZILAGYI, L ;
RUTTER, WJ .
SCIENCE, 1992, 255 (5049) :1249-1253
[7]  
IYANIWURA TT, 1991, VET HUM TOXICOL, V33, P475
[8]   DETERMINATION OF OPERATIONAL MOLARITY OF SOLUTIONS OF BOVINE ALPHA-CHYMOTRYPSIN, TRYPSIN, THROMBIN AND FACTOR XA BY SPECTROFLUORIMETRIC TITRATION [J].
JAMESON, GW ;
ROBERTS, DV ;
ADAMS, RW ;
KYLE, WSA ;
ELMORE, DT .
BIOCHEMICAL JOURNAL, 1973, 131 (01) :107-117
[9]   The recombinant Escherichia coli-derived protease domain of tissue-type plasminogen activator is a potent and fibrin specific fibrinolytic agent [J].
Kohnert, U ;
Hellerbrand, K ;
Martin, U ;
Stern, A ;
Popp, F ;
Fischer, S .
FIBRINOLYSIS, 1996, 10 (02) :93-102
[10]   The 2.3 angstrom crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator [J].
Lamba, D ;
Bauer, M ;
Huber, R ;
Fischer, S ;
Rudolph, R ;
Kohnert, U ;
Bode, W .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 258 (01) :117-135